Risk of mortality between warfarin and direct oral anticoagulants: population-based cohort studies
The differences in hazard of all-cause mortality associated with warfarin compared with DOAC, in part may depend on anticoagulation control in warfarin users. Notably, this study is unable to establish a causal relationship between warfarin and mortality stratified by TTR, versus DOACs, requiring future studies for further investigation.
Authors
- Celine Sze Ling Chui (ORCID: https://orcid.org/0000-0003-1513-8726)
- Angel Y. S. Wong (ORCID: https://orcid.org/0000-0002-8618-7333)
- John Tazare (ORCID: https://orcid.org/0000-0002-7194-2615)
- Julian Matthewman (ORCID: https://orcid.org/0000-0003-3291-2381)
- Zixuan Wang (ORCID: https://orcid.org/0000-0001-5345-2471)
- Liam Smeeth (ORCID: https://orcid.org/0000-0002-9168-6022)
- Esther W. Chan (ORCID: https://orcid.org/0000-0002-7602-9470)
- Krishnan Bhaskaran (ORCID: https://orcid.org/0000-0001-5364-8757)
- Ka Shing Cheung (ORCID: https://orcid.org/0000-0002-4838-378X)
- Ian Douglas (ORCID: https://orcid.org/0000-0002-8970-1406)
- Qiuyan Yu (ORCID: https://orcid.org/0000-0002-5385-7185)
- Ian Chi Kei Wong (ORCID: https://orcid.org/0000-0001-8242-0014)
Institutions
- Department of Health (CN)
- Aston University (GB)
- Queen Mary Hospital (CN)
- London School of Hygiene & Tropical Medicine (GB)
- University of Hong Kong - Shenzhen Hospital (CN)
- Laboratory of Data Discovery for Health (HK)
- University of Birmingham (GB)
- University of Hong Kong (HK)
Publication Details
- Journal
- BMC Medicine
- Published
- 2024-12-23
- DOI
- https://doi.org/10.1186/s12916-024-03808-y
- Citations
- 1
- Primary Topic
- Atrial Fibrillation Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.40
Funders
- Innovation and Technology Commission